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Abstract
Oral tissues are constantly exposed to damage from the mechanical effort of eating and 
from the invasion of foreign microorganisms such as bacteria, fungi, and virus. In 
healthy oral tissues, there is a balance between symbiotic bacteria and cells from the 
innate immune system, mainly neutrophils. When this balance is broken, inflammation 
appears and more immune cells are recruited to the gingiva. Neutrophils form a barrier 
against dysbiotic bacteria. However, when neutrophils are insufficient, bacteria thrive 
causing periodontitis, a chronic inflammatory disease that destroys the tooth‐supporting 
tissues or periodontium. Damage of periodontal tissues leads to tooth loss, and in severe 
cases, it can also affect systemic health by increasing a person's risk for atherosclerosis, 
rheumatoid arthritis, diabetes, and even cancer. The mechanisms neutrophil employ to 
keep a balance with bacteria in order to maintain healthy oral tissues is the focus of this 
chapter. We discuss how neutrophil antimicrobial functions keep bacteria at check and 
how some dysbiotic bacteria block neutrophils to promote an inflammatory state. Also, 
novel therapeutic approaches for periodontitis are discussed.
Keywords: neutrophil, phagocytosis, degranulation, NETs, oral microbiota, dysbiotic 
microbiota
1. Introduction
Periodontal disease is a major public health problem due to its high prevalence worldwide 
[1]. Periodontitis is a more advanced inflammatory form of periodontal disease. It is a chronic 
inflammatory disease that causes tooth loss, by destroying the periodontium. Periodontal 
destruction may be caused by different factors, including accumulation of dental biofilm, poor 
oral hygiene, and loss of balance between oral microbiota and immune response. Dysbiosis 
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(an alteration of oral microbiota) is thought to be the initial trigger for periodontitis [2]. The 
accumulation of bacteria biofilm leads to an increase in the inflammatory infiltrate, composed 
mainly by neutrophils into oral tissues. In this chapter, we will discuss the role of neutrophils 
in periodontal disease.
2. Neutrophil homeostasis
Neutrophils are considered to be the first line of defense during infections and inflammation 
[3]. They are the most abundant leukocytes in blood and can live for much longer than pre‐
viously thought. It is estimated that neutrophils half‐life is days instead of hours [4]. When 
microorganisms invade the organism, an inflammatory response is induced. Neutrophils are 
recruited from the circulation into the tissues where they destroy microorganisms by phagocy‐
tosis, by releasing antimicrobial substances, or by NETosis (Figure 1). This last mechanism was 
Figure 1. Neutrophil homeostasis involves production, trafficking, and clearance of these cells. (A) Production of 
neutrophils takes place at the bone marrow. Neutrophils maturate in the bone marrow accumulating different granules 
(arrow heads), azurophil, specific, and gelatinase. Finally, they also produce secretory vesicles. Lines show the moment 
of appearances of granules and vesicles. Neutrophils are released from the bone marrow to the circulation by interfering 
with the CXCR4‐CXCL12 interaction. (B) Neutrophils mobilization to infection site through a leukocyte adhesion 
cascade that includes capture, rolling, firm adhesion, and transmigration of neutrophils (thin arrows). Senescent 
circulating neutrophils increase the expression of CXCR4, and respond to CXCL12 by homing back to the bone marrow. 
(C) Neutrophils kill bacteria by phagocytosis, degranulation, and NETs formation. Apoptotic neutrophils are cleared by 
macrophage phagocytosis. The process of “neutrostat” that maintains steady‐state neutrophil levels (molecules with 
green background and green arrows). In an infected site, macrophages produce IL‐23, which activates IL‐17. IL‐17 
induces G‐CSF that promotes neutrophil differentiation and release from the bone marrow (thick arrows). After 
macrophages phagocyte apoptotic neutrophils, they downregulate the production of IL‐23 and produce IL‐10 and 
TGF‐β, this events stop the recruitment of neutrophils. CXC, chemokine receptor; IL, interleukin; G‐CSF, granulocyte 
colony‐stimulating factor.
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recently discovered and consists on the formation of neutrophil extracellular traps (NETs) [5]. 
Activated neutrophils produce a variety of chemokines and cytokines, directing the inflam‐
matory and the immune responses [6]. Unfortunately, if there is not a proper clearance of 
neutrophils after an infection, the proteases released from neutrophils into the surrounding 
tissue can cause damage to the host [7]. Bacteria biofilm deposited on teeth induces a constant 
recruitment of neutrophils (>95%) to the gingival sulcus (Figure 2) [8, 9]. Therefore, neutrophil 
homeostasis is important to prevent collateral damage to the host by the potent proinflamma‐
tory and antimicrobial effects of these cells. As neutrophils are the most abundant leukocytes, 
their excess or absence in the mouth leads to periodontal tissue damage. Moreover, neutro‐
phil distribution and numbers are essential in maintaining oral health. Neutrophil homeostasis 
involves production, trafficking, and clearance of these cells [10].
2.1. Production
Thousands of neutrophils are daily produced in the bone marrow and released into the cir‐
culation [11]. Three pools of neutrophil population reside in the bone marrow: the stem cell 
pool, the mitotic pool, and the postmitotic pool (Figure 1A). The first pool consists of undif‐
ferentiated pluripotent hematopoietic stem cells (HSCs), the second pool consists of committed 
granulocytic progenitor cells that proliferate and differentiate. Finally, the third pool consists 
of fully differentiated neutrophils, which form the bone marrow reserve, available for release 
[12]. HSCs differentiate into myeloblasts, a developmental cell type committed to becoming 
granulocytes (Figure 1A). Granulocyte colony‐stimulating factor (G‐CSF) regulates both, pro‐
duction or granulopoiesis, and neutrophil release from the bone marrow. G‐CSF regulates 
granulopoiesis by inducing proliferation of granulocytic precursors in the bone marrow [10]. 
A large postmitotic pool is retained in the bone marrow by the interaction of CXC chemokine 
receptor 4 (CXCR4) on neutrophils with chemokine CXCL12 (stromal‐derived factor‐1/SDF‐1) 
Figure 2. Neutrophil infiltrate and inflammation state. (A) In health conditions few neutrophils are recruited to the 
gingival sulcus to maintain symbiotic microbial community and the gum is not inflamed. (B) During gingivitis more 
neutrophils are recruited to the gingival sulcus and the gum in moderate inflamed. The junctional epithelium is starting 
to detach from the tooth. (C) During periodontitis a mayor neutrophil infiltrate is recruited to the periodontal pocket and 
the gum in severely inflamed. Inflammatory response activates osteoclasts, which in turn reabsorb bone.
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produced by bone marrow stromal cells (Figure 1A). G‐CSF regulates mature neutrophil 
release from the bone marrow by interfering with the CXCR4‐CXCL12 interaction [12]. In addi‐
tion, interleukin‐17 (IL‐17) endorses granulopoiesis and neutrophil release by upregulation of 
G‐CSF (Figure 1) [10]. IL‐17 builds on an interesting positive loop of neutrophil recruitment. 
For example, in chronic inflammation sites, neutrophils produce IL‐17 and can also attract 
IL‐17‐producing CD4+ T lymphocytes (Th17 cells) [13]. Neutrophils also release CCL20 and 
CCL2 chemokines, which are ligands for CCR6 and CCR2 chemokine receptors, respectively, 
on Th17 cells. This interaction maintains Th17 cells at inflammation sites. Therefore, Th17 cells 
secrete more IL‐17 and more neutrophils are recruited [14].
2.2. Trafficking
Circulating neutrophils can be quickly mobilized to infection or inflammation sites through a 
systematically controlled process known as the leukocyte adhesion cascade, which achieves 
neutrophil transmigration (Figure 1B) [15]. The process initiates when endothelial cells 
get activated and upregulated the expression of adhesion receptors such as E‐ and P‐selec‐
tins. Neutrophils recognize these selectins and begin rolling on endothelial cells. This roll‐
ing depends on transient interactions of selectins with glycoprotein ligands on neutrophils. 
Next, neutrophils get activated by chemokines, which induce a high affinity state in integrins, 
another group of adhesion receptors. Interaction of both selectins and integrins with their cor‐
responding ligands leads to slow neutrophils rolling followed by a firm adhesion that brings 
neutrophils to a full stop. Finally, neutrophils crawl on the endothelium and transmigrate into 
infection or inflammation sites. This last process is regulated mainly by β2 integrins. Integrins 
are heterodimeric receptors formed by a unique α (CD11) and a common β (CD18) subunit 
that interact with adhesion ligands such as intercellular adhesion molecule‐1 (ICAM‐1) and 
ICAM‐2 on endothelial cells (Figure 1B). This leukocyte adhesion cascade is positive regu‐
lated by tissue‐derived cytokines and by tissue‐derived chemokines. Cytokines control the 
expression of endothelial adhesion molecules and chemokines induce integrins to change 
conformation into a high affinity state [16]. Once neutrophils move into tissues, they follow 
chemoattractant gradients to reach infection or inflammation sites. Some chemoattractants for 
neutrophils are activated by complement components, such as the anaphylatoxin C5a, and 
bacterial components, such as formyl‐methionyl‐leucyl‐phenylalanine (fMLF). Recently, it has 
been discovered that the leukocyte adhesion cascade is also negatively regulated by endog‐
enous inhibitors such as Del‐1 (developmental endothelial locus‐1), pentraxin 3, and growth‐
differentiation factor 15 [17].
2.3. Clearance
Neutrophils are mostly cleared in tissues (Figure 1C) and possibly also in the bone mar‐
row (Figure 1A). In tissues, once neutrophils have completed their antimicrobial duty, 
they undergo apoptosis. Resident phagocytes, for instance, macrophages and dendritic 
cells, clear neutrophils locally. Phagocytosis of apoptotic neutrophils reprograms mac‐
rophages to initiate an anti‐inflammatory response, characterized by the synthesis of 
tumor growth factor (TGF)‐β and IL‐10, and by a reduction in IL‐23 synthesis (Figure 1) 
[18]. IL‐23 cytokine induces IL‐17 synthesis; thus, the reduced IL‐17 levels lead to less 
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G‐CSF production and in  consequence, less neutrophil production. This process is a 
control loop that has been described as a “neutrostat” (neutrophil rheostat), and main‐
tains steady‐state neutrophil levels (Figure 1) [14]. Senescent circulating neutrophils are 
recruited for clearance in the bone marrow. These neutrophils increase the expression 
of CXCR4, and respond to CXCL12 by homing back to the bone marrow (Figure 1) [19]. 
Apoptosis and proper removal of apoptotic cells are key aspects of inflammation resolu‐
tion. Neutrophils death is influenced by environmental conditions including hypoxia and 
presence of inflammatory mediators, such as granulocyte/monocyte colony‐stimulating 
factor (GM‐CSF) and lipopolysaccharides (LPS). Neutrophil clearance depends on signals 
that apoptotic neutrophils express on their surface. These signals allow macrophages to 
recognize and ingest the neutrophils (Figure 1C) [20]. Failure to clear these apoptotic cells 
results in secondary necrosis and release of products that generate proinflammatory sig‐
nals. Neutrophils express molecules that regulate their survival. Some of these molecules 
are survivin, cyclin‐dependent kinases and proliferating cell nuclear antigen (PCNA). 
Survivin is expressed more highly in immature neutrophils than in mature ones, but its 
expression can be reestablished in mature cells by inflammatory signals, for instance, GM‐
CSF or G‐CSF [21]. Similarly, cyclin‐dependent kinases function as prosurvival factors. 
Their inhibition induces caspase‐dependent apoptosis. PCNA in neutrophils associates 
with procaspases in the cytosol and is thought to prevent their activation. During apopto‐
sis, PCNA is targeted for proteosomal degradation, which correlates with an increase in 
caspase‐3 and caspase‐8 activities [11].
3. Neutrophils in oral health
Commonly, it is thought that microbes are harmful to our health. Contrary to this thought, 
there are plenty of microbes that harmoniously live within our bodies and form our micro‐
biota. Homeostasis between the host and its symbiotic microbiota is a key factor to under‐
stand and maintain our health [22, 23]. Nevertheless, we are constantly exposed to microbes 
not belonging to our microbiota through the things we touch, the food we eat, and the air we 
inhale. Fortunately, our innate immune system protects us from this constant threat. The oral 
cavity is a special place, where the microbiota is constantly changing. Yet, homeostatic mecha‐
nisms exist that keep the oral microbiota in balance with the immune system. Neutrophils 
are actively recruited into the gingival sulcus by an interleukin (IL)‐8 gradient continuously 
secreted by the junctional epithelium, as this tissue is in close contact with the oral biofilm 
bacterial community (Figure 2). Neutrophils are mostly responsible for ensuring periodontal 
health by keeping this biofilm at check [24]. However, during gingivitis a moderate inflam‐
matory response is generated. If this inflammation is not controlled, for example, in situations 
or poor oral hygiene, gingivitis can lead to periodontitis, a chronic inflammatory disease. 
In this condition, microbial pathogens cannot be eliminated or controlled by neutrophils. In 
response, more neutrophils are recruited to the periodontal tissue. Neutrophil accumulation, 
instead of protecting, favors periodontal tissue damage and even bone loss (Figure 2). Thus, 
a close balance between neutrophil function and microbe challenge must be maintained to 
ensure periodontal health.
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4. Antimicrobial mechanisms of neutrophils
Neutrophils are equipped with different antimicrobial mechanisms, which help them to fight 
a broad spectrum of bacteria, fungi, and protozoa. These mechanisms include phagocytosis, 
degranulation, and neutrophil extracellular traps (NETs) (Figure 1).
4.1. Phagocytosis
Phagocytosis is a receptor‐mediated process during which a particle is internalized by the cell 
into a vacuole called the phagosome. Neutrophils recognize pathogens through pattern‐rec‐
ognition receptors (PAMPs), or opsonins (antibody molecules or complement components). 
Opsonized pathogens are efficiently phagocytosed when they bind with antibody receptors 
(Fc receptors) or complement receptors on the neutrophil (Figure 3). After engulfment, the 
nascent phagosome matures by fusing with lysosomes. This brings antimicrobial molecules 
into the phagosomal lumen. The vesicle is now called phagolysosome. Concurrently, reactive 
oxygen species (ROS) production starts by the assembly of the NADPH oxidase on the phago‐
somal membrane, and the pH inside the phagosome drops to 4.5–5. Also, potassium ions (K+) 
are pumped into the phagolysosome; this K+ influx mediates the release of serine proteases. In 
addition, hydrogen peroxide (H
2
O
2
) is also converted into hypochloric acid (HOCl) in a reac‐
tion catalyzed by myeloperoxidase (MPO) [25]. Granules content and ROS create an environ‐
ment toxic to the pathogen. Unfortunately, not all pathogens are killed inside the phagosome. 
Moreover, some have advanced strategies to survive inside neutrophils. These strategies 
include interfering with engulfment, modulating phagosome maturation, and creating a more 
hospitable intraphagosomal environment.
Figure 3. Phagocytosis and NETs. (A) Neutrophils recognize opsonized pathogens through Fc Receptors (FcγRIIa) 
or complement receptors (Mac‐1) on their membrane. The pathogen is internalized into a nascent phagosome, which 
matures by fusing with lysosomes forming a phagolysosome. (B) Neutrophil extracellular traps (NETs) are formed when 
neutrophils release decondensed chromatin decorated with antimicrobial molecules, into the extracellular space. ROS, 
reactive oxygen species.
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4.2. Degranulation
In the bone marrow, as precursor cells mature into neutrophils, they synthesize proteins that 
are sorted into different granules [26]. Granules formation begins in early promyelocytes 
and continues throughout the various stages of myeloid cell development. The granules are 
 arbitrarily subdivided into three different classes based on their resident cargo molecules: 
azurophilic, specific, and gelatinase granules (Figure 1A, Table 1). Neutrophils also form 
secretory vesicles until the last step of their differentiation (Figure 1A, Table 1). Granule het‐
erogeneity is explained by regulated expression of the granule protein genes. This regulation 
is mediated by the combination of myeloid transcription factors that express at specific stages 
of neutrophil development. Vesicle availability and exocytosis depends on mobilizable intra‐
cellular compartments of the neutrophil. Mature neutrophils are released into the circulation 
and, in response to infection, they leave the circulation and migrate toward the inflamma‐
tory site. Exocytosis of granules and secretory vesicles plays a crucial role in most neutrophil 
functions from early activation to the destruction of phagocytosed microorganisms. Secretory 
vesicles have the highest propensity for extracellular release, followed by gelatinase granules, 
specific granules, and azurophil granules [27, 28]. For example, neutrophil stimulation with 
phorbol myristate acetate (PMA) induces complete release of gelatinase granules, restrained 
release of specific granules, and minimal exocytosis of azurophil granules. In a different 
way, neutrophil stimulation with fMLF induces release of mostly secretory vesicles without 
Azurophil granules Specific granules Gelatinase granules Secretory vesicles
Azurocidin CD11b/CD18 Acetyltransferase Alkaline phosphatase
Bacterial/permeability‐
increasing protein
Cathelicidin CD11b/CD18 CD11b/CD18 (CR3)
Collagenase Cytochrome b558 CD14
Cathepsins Cytochrome b558 Gelatinase CD16
Defensins fMLP‐R Leukolysin CR1
Lysozyme Lactoferrin Lysozyme Cytochrome b558
Myeloperoxidase Leukolysin Natural‐resistance‐
associated macrophage 
protein 1 (NRAMP1)
FRP
Natural serine proteases Lysozyme fMLF‐R
Cathepsin G Neutrophil gelatinase‐
associated lipocalin 
(NGAL)
Neutrophil elastase
Proteinase 3
Note: CR, complement receptor; FPR, formyl peptide receptor; NGAL, neutrophil gelatinase‐associated lipocalin; 
NRAMP1, natural‐resistance‐associated macrophage protein 1.
Table 1. Cytoplasmic granules of neutrophils [24–26, 28].
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 significant release of granules. The hierarchical mobilization of neutrophil granules and secre‐
tory vesicles depends on intracellular Ca2+ level. Gradual elevations in intracellular Ca2+ are 
induced by ligation of L‐selectin, CD11b/CD18, and the fMLP receptors [26].
4.3. Neutrophil extracellular traps (NETs)
Neutrophil stimulation can also undergo a mechanism called NETosis. Although NETosis 
has previously been described as a special form of programmed cell death, there are forms of 
NET production that do not end with the demise of neutrophils. NETosis leads to the release 
of decondensed chromatin into the extracellular space. The chromatin forms a trap for patho‐
gens that looks like a net, which is why they are called neutrophil extracellular traps (NETs). 
NETs also contain histones, cytoplasmic proteins, and antimicrobial granular molecules. 
NETs formation mechanisms are still unknown, nevertheless, NADPH oxidase activation, 
reactive oxygen species (ROS) production, myeloperoxidase (MPO), and neutrophil elastase 
(NE) release (Figure 3) are required [25].
5. Neutrophil interactions with symbiotic oral bacteria
In periodontal health, the interaction between symbiotic microbial community and neutrophils is 
strongly controlled to prevent tissue damage. This interaction has been evaluated in studies with 
germ‐free mice and specific pathogen‐free mice. Results of these studies showed that oral sym‐
biotic commensal microbiota has no impact on the structure of gingival tissue of germ‐free mice, 
while gut commensal microbiota is fundamental on the structural formation of the intestinal 
tissue [29]. Periodontal tissue recruits neutrophils by means of the chemotactic receptor CXCR2. 
This receptor has two ligands CXCL1 and CXCL2. Both ligands are expressed in the junctional 
epithelium of germ‐free and specific pathogen‐free mice, but there is a significant increase on 
CXCL2 in the epithelium of specific pathogen‐free mice. Therefore, oral bacterial community 
induces an increase in neutrophil recruitment via CXCL2 [29]. Neutrophils play a key role in 
preserving oral health, since low neutrophil counts as well as deficiency in neutrophil functional 
responses have been associated with periodontal disease. As mentioned before, neutrophils kill 
pathogens by phagocytosis, degranulation, or NETs formation (Figure 1C). Neutrophils are very 
efficient phagocytic cells and have a very efficient antimicrobial mechanism to do so, the respira‐
tory burst response. In this response, high consumption of oxygen results in the production of 
reactive oxygen species (ROS), through the activation of the NADPH oxidase complex (Figure 3) 
[5]. Patients with chronic granulomatous disease, a rare genetic disorder that consist on muta‐
tions in the NADPH oxidase, are inefficient in mounting a respiratory burst response. As a con‐
sequence, these patients present early in life recurrent infections [30]. These patients present 
higher bacteria colonization and gingivitis; however, they do not present periodontitis [31].
6. The evolution from a healthy periodontium to periodontitis
In the oral cavity, the tooth surface offers a niche for bacteria colonization and biofilm forma‐
tion resulting in a varied polymicrobial community. A healthy environment is maintained if the 
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 multiplication of symbiotic microbiota is regulated. Periodontal diseases are related to a shift 
from symbiotic microbiota to dysbiotic microbiota, and this shift is related with the accumula‐
tion of dental plaque or biofilm. Biofilm elaboration consists of four sequential phases. Phase 1 
consists of the adsorption of different molecules to a surface to condition the biofilm formation. 
Phase 2 consists of single organism adhesion. Phase 3 consists of growth of extracellular matrix 
production and multiplication of adhering bacteria and phase 4 consists of sequential adsorption 
of further bacteria to form a more complex and mature biofilm (Figure 4) [32]. The microbial eti‐
ology of gingivitis and periodontitis has been established for several decades. In 1994, Haffajee 
and Socransky adapted Koch's postulates to be used in the identification of periodontal patho‐
gens. In 1996, at the World Workshop in Periodontics three species of pathogens were identified 
as causative factors of periodontitis Aggregatibacter actinomycetemcomitans, Porphyromonas gingi-
valis, and Tannerella forsythia; however, these three species cannot be considered to be the only 
causative pathogens of periodontitis, but we are certain that they participate in the disease [32].
Figure 4. Biofilm elaboration consists of four sequential phases. Phase 1 consists of the adsorption of different molecules 
to a surface to condition the biofilm formation. Phase 2 consists of single organism adhesion. Phase 3 consists of growth 
of extracellular matrix production and multiplication of adhering bacteria and phase 4 consists of sequential adsorption 
of further bacteria to form a more complex and mature biofilm. The first two phases are representative of health, phase 
3 of gingivitis, and phase 4 of periodontitis.
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6.1. Balanced inflammation
Neutrophils are the main leukocytes recruited to the gingival sulcus. Neutrophils exit the 
gingival blood vessels and travel through the gingival junctional epithelium until they reach 
the sulcus [8]. In the sulcus, neutrophils create a barrier against the growing bacteria biofilm 
to prevent bacteria from invading the underlying tissues. Neutrophil migration from vessels 
toward the gingival sulcus requires CXCR2 binding to CXCL2. Migration is controlled by 
gradients of chemokines and adhesion molecules such as IL‐8, ICAM‐1, and E‐selectin [29]. 
Neutrophil presence in the sulcus is necessary to preserve oral health since patients with 
altered neutrophil production and distribution develop severe periodontitis at early ages 
[33]. Chédiak‐Higashi syndrome, Papillon‐Lefèvre syndrome, neutropenias, and leukocyte 
adhesion deficiency (LAD) are some examples of neutrophil diseases. In Papillon‐Lefèvre 
syndrome neutrophils have defective chemotaxis, as a consequence, they are not efficiently 
recruited to the sites of inflammation and infection [34]. Neutropenia, a persistent reduction 
of neutrophil numbers in circulation, is frequently associated with susceptibility to infections. 
In many neutropenic conditions, severe periodontal disease is recurrently seen since primary 
dentition eruption [35]. CXCR2‐deficient mice cannot recruit neutrophils to oral tissues. These 
mice also experience periodontitis and periodontal bone loss early in life [36]. Leukocyte 
adhesion deficiency is a group of inherited disorders, in which neutrophils fail to transmi‐
grate from the circulation to the site of inflammation or infection. Neutrophils of patients 
with leukocyte adhesion deficiency have defective expression and function of adhesion mol‐
ecules like integrins. Therefore, neutrophils cannot adhere firmly to the vascular endothelium 
to transmigrate. Even though the presence of neutrophils is necessary to control infections, 
plenty of neutrophils on a site of infection is not always protective. In fact, neutrophil num‐
bers in inflamed periodontal tissues correlate with the severity of the lesions [37], and tissue 
destruction seems to be a collateral damage of hyperactive neutrophils [38].
6.2. Periodontitis
Periodontal diseases cause the destruction of the tooth supporting tissues, gingiva, periodontal 
ligament, cement, and alveolar bone and may eventually lead to tooth loss. Severe periodontitis 
affects approximately 10% of the global population [39]. Periodontal disease is the consequence 
of a shift in oral microbiota population from a symbiotic to a dysbiotic microbial community in 
the mouth. Periodontal disease begins when some factors that promote the growth of selected 
symbiotic bacteria, induce host inflammatory pathways [40, 41]. Periodontitis not only severely 
deteriorates people's quality of life by impairing the dentition but also adversely affect systemic 
health. A clear correlation between periodontal disease and atherosclerosis has been estab‐
lished in  clinical observations and in animal models. In particular, polymicrobial infection with 
Treponema  denticola, Porphyromonas gingivalis, Tannerella forsythia, and Fusobacterium nucleatum has 
been shown to promote progression of atherosclerosis [42]. Another correlation between peri‐
odontitis and diabetes also has been well documented. Higher plaque levels and higher incidence 
of chronic gingivitis are both found in adults and in children with diabetes [43, 44]. Periodontal 
treatment showed a beneficial effect on metabolic control of type 2 diabetic patients. Other various 
systemic diseases such as diabetes, cardiac disease, low birth weight, renal diseases,  metabolic 
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syndrome, obesity, Parkinson's disease, and Alzheimer's disease have been also proposed to be 
linked with periodontal disease on the basis of systemic inflammation [40, 41, 45].
6.3. Inflammation in periodontitis
Periodontitis is associated with a change in oral microbiota from symbiotic bacteria to dysbiotic 
anaerobic microorganisms, which have adapted to succeed in an inflammatory environment 
(Figure 4). Pathogenic bacteria, such as Porphyromonas gingivalis, induce changes in the normal 
microbiota of the gingival crevicular fluid, leading to increased biofilm deposition in the gin‐
gival sulcus. The gingival sulcus is the space between the tooth surface and the free gingiva. 
Pathogenic bacteria also induce moderate inflammation known as gingivitis (Figure 4). When 
this moderate inflammation is not well resolved, a chronic inflammatory state is established, 
which results in the formation of pathologically deepened gingival sulcus also called periodon‐
tal pockets, followed by extensive tissue destruction, including bone loss (Figures 2 and 4). 
These last events are induced by the accumulation of dysbiotic bacteria in the periodontal pock‐
ets and are thought to be the initial trigger for periodontitis [46]. Accumulation of dysbiotic 
bacteria biofilm leads to an increase in the inflammatory infiltrate, composed mainly by neu‐
trophils into oral tissues. There, neutrophils form a barrier that prevents bacteria from invading 
deeper tissues and are essential for maintaining healthy oral tissues. In the case of neutrophils 
deficiencies, severe periodontitis appears with a concomitant inflammation state. On the con‐
trary, excess numbers of neutrophils induces a chronic inflammatory state. Thus, inflammation 
is an important element in periodontitis that is deregulated when neutrophil homeostasis is 
altered. Periodontitis in the absence of neutrophils has traditionally been explained by the lack 
of neutrophil control on bacterial infections. Patients with leukocyte adhesion deficiency pres‐
ent frequent infections and develop early severe periodontitis. However, this type of periodon‐
titis does not usually respond to treatment with antibiotics or mechanical removal of bacteria 
biofilm, suggesting that other mechanisms are at work. Recently it was shown that the driving 
force for this type of periodontitis involves the production of IL‐23 and IL‐17. In leukocyte 
adhesion deficiency type 1 patients, T cells were identified as the main producers of IL‐17 [47]. 
IL‐17 not only stimulates fibroblasts to produce G‐CSF but also promotes inflammation and 
stimulates osteoclasts, leading to bone loss. These findings are in agreement with the neutrostat 
mechanism discussed above. When apoptotic neutrophils are phagocytosed by macrophages, 
anti‐inflammatory signals are produced that lead to less IL‐23 production, which is a strong 
inducer for IL‐17 production. IL‐17 in turn induces G‐CSF production (Figure 1).
Neutrophils can be found in large numbers in inflamed periodontal tissues, and their pres‐
ence correlates with the severity of the periodontal destruction. Therefore, this destruction 
seems to be collateral damage of hyperactive neutrophils [48, 49]. Neutrophil recruitment 
is at least in part regulated by Del‐1 and LFA‐1 interactions. Del‐1 blocks LFA‐1 binding to 
its ligand ICAM‐1 and prevents neutrophil transmigration [50]. Neutrophil recruitment is 
also triggered with elevated IL‐17 levels, which resulted to be responsible for the tissue dam‐
age, because antibodies against IL‐17 prevented inflammation and bone loss. High levels of 
IL‐17 could be responsible for the bone loss in chronic periodontitis, by stimulating osteoblast 
expression of RANKL, an important osteoclastogenesis factor.
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6.4. Dysbiotic bacteria
Diverse environments present in the oral cavity allow symbiotic and dysbiotic microbiota to find 
the best niche that fits their growth requirements, resulting in the formation of unique microbial 
biofilm communities. Periodontal disease microbiota includes a large number of microorgan‐
isms including P. gingivalis, Tannerella forsythia, and Treponema denticola [51]. Fortunately, nucleic 
acid screening and 16S pyrosequencing techniques have made more efficient finding changes 
in microbiota of healthy and of periodontal disease patients [52]. Screenings have been made 
at nine different oral sites including the oral epithelium, the maxillary anterior vestibule, the 
dorsum and lateral tongue surface, the hard and soft palate, the tonsils, the tooth surfaces, and 
the subgingival plaque [53, 54]. There are between 100 and 300 bacterial species in a single indi‐
vidual. Our general idea is that infectious diseases are caused by the action of a single foreign 
pathogen. However, periodontitis is originated by the complex association and interaction of 
a diverse polymicrobial community [37, 51, 55]. Data obtained from oral biofilm studies using 
checkerboard DNA‐DNA techniques link the different stages of the disease to a specific bacterial 
group or complex with the presence of the triad of bacteria composed by P. gingivalis, T. forsythia, 
and T. denticola, which are strongly associated with increased severity of periodontitis [56]. Other 
microorganisms have also been identified such as F. alocis, a Gram‐positive bacterium, which 
is present in periodontal disease sites, while Veillonella sp, a Gram‐negative uncultivated bac‐
terium, is associated with healthy periodontal sites. This data indicates that the general idea of 
Gram‐negative anaerobic bacteria being the pathogen population is not completely correct.
In a healthy gingival tissue, the local symbiotic microbiota is less diverse and rich, with neutro‐
phil recruitment to clear the infection and resolving the inflammation with no collateral dam‐
age to the host (Figures 4 and 5). The progression from health to periodontitis is now explained 
as the transition from a symbiotic microbiota to a polymicrobial dysbiotic microbiota. Several 
risks factors, such as smoking, tissue injury, diet changes, an immunocompromised host, or the 
colonization of the oral cavity by pathogenic bacteria can modify the oral ecosystem resulting 
in a dysbiotic polymicrobial community. In consequence, the host's response toward the poly‐
microbial dysbiotic microbiota challenge is more robust and not regulated, transitioning from 
a controlled/stable immune response into a nonresolving chronic inflammatory response [57].
Polymicrobial dysbiotic microbiota has an arsenal of self‐defense mechanisms, which can be 
directed to attack against neutrophils or camouflage the biofilm (Figure 5) [58]. Microbiota 
has an intermicrobial communication called quorum sensing, that enables the dysbiotic 
microbiota to optimize the biofilm conditions and ensure nutrient supply. Among the defense 
mechanisms, the production of bacterial surfactants by P. aeruginosa biofilms causes rapid cell 
death in neutrophils [59]. Additionally, quorum sensing molecules control neutrophil ROS 
response and penetration into P. aeruginosa biofilms [60]. Similarly, Aggregatibacter actinomy-
cetemcomitans and S. aureus produce bacterial toxins that induce neutrophils lysis and degran‐
ulation [61–63]. In addition to directly attacking neutrophils, dysbiotic microbiota in biofilms 
can render themselves resistant to neutrophil‐mediated killing by disguising their immuno‐
genicity. NET formation within Haemophilus influenzae biofilms does not harm the biofilm. 
This is presumably due to their expression of certain lipooligosaccharide glycoforms, which 
shield pathogen‐associated molecular patterns (PAMPs) and thus inhibit recognition and 
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opsonization. This molecule can provide protection against antimicrobial peptides [64]. One 
important microbial defense mechanism is the evasion of phagocytosis. Prevotella strains 
were recognized by neutrophils but not phagocytosed, depending on whether they produced 
mannose‐rich exopolysaccharides as part of their extracellular matrix [65]. S. aureus is able to 
survive after being phagocytosed by neutrophils [66]. S. aureus is known to be potent triggers 
Figure 5. Neutrophil response in periodontal health and disease. Health: Symbiotic bacteria community adheres to 
molecules of the salivary pellicle that are bound to the tooth surface. Few neutrophils patrol the gingival sulcus, and as 
the bacterial burden increases, neutrophils regularly exit the blood stream entering the connective tissue layer beneath 
the junctional epithelium and the tooth and kill some of the associated microbes (thin arrows). Neutrophils maintain 
bacterial concentration so there is no inflammation or tissue damage (arrow heads). Disease: Following the presence 
of a risk factor (smoking, poor diet, injury, etc.; thick arrow) dysbiotic bacteria (big oval) can colonize the symbiotic 
microbial community. Following colonization, the sulcus is invaded by dysbiotic bacteria which shut down the IL‐8 
production. Neutrophils enter the connective tissue, but do not get to the sulcus. This causes many neutrophils to 
accumulate in the connective tissue. As some neutrophils transmigrate to the dysbiotic biofilm increase inflammation 
is conducted by neutrophil degranulation, reactive oxygen species (ROS) production, and NETosis that damages the 
host tissue.
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for NETosis and degranulation. Therefore, it can be assumed that implementation of such 
survival strategies coexists with the elimination of bacteria by neutrophils. Finally, inflamma‐
tion and tissue destruction mediated by neutrophils evoke frequent gingival bleeding, which 
these bacteria may use as an additional source of nutrients, such as iron and vitamin K.
7. Porphyromonas gingivalis
Porphyromonas gingivalis are anaerobic, Gram‐negative, nonmotile, asaccharolytic rods that 
usually exhibit coccal or short rod morphologies. It is part of the black‐pigmented Bacteriodes 
group [32]. P. gingivalis, even in low colonization levels, can induce the shift from symbiotic 
microbiota to dysbiotic microbiota followed by inflammatory bone loss. This bacteria uses 
different mechanisms to destabilize neutrophil homeostasis, inhibition of phagocytic kill‐
ing, resistance to granule‐derived antimicrobial agents and to the oxidative burst, impaired 
recruitment and chemotaxis, promote inflammatory response, and delay of neutrophil apop‐
tosis. P. gingivalis has a number of virulence factors related to the subversion of the innate 
immune system. This ability is what often characterizes a successful pathogen, as it tends to 
disable the overall host response while simultaneously enhancing the pathogenicity of a poly‐
microbial community. P. gingivalis are resistant to oxidative killing [67] and recruit hyperac‐
tive neutrophils with an enhanced response, which is characterized by the release of reactive 
oxygen intermediates, several cationic peptides, and enzymes such as matrix metalloprotein‐
ases (MMPs). All this responses increased tissue damage [48]. P. gingivalis also can manipulate 
both complement and TLR signaling to induce bacterial persistence.
Porphyromonas gingivalis gingipains are able to trigger the expression of proinflammatory sur‐
face receptor TREM‐1 on neutrophils, and several periodontopathogenic species can induce 
IL‐8 gene expression in gingival epithelial cells and fibroblasts [68, 69].
8. Treponema denticola
Treponema denticola is an anaerobic, Gram‐negative, motile, spirochete that can be poorly detected 
in the gingival plaque of healthy individuals. However, it is present in very high numbers in 
the subgingival periodontal pocket and is associated with the dysbiotic microbiota biofilm for‐
mation in periodontal lesions. T. denticola limits neutrophil chemotaxis, and inhibits junctional 
epithelial cells to secrete IL‐8. Additionally, this pathogen is able to degrade IL‐8 that is already 
present at the infection site, which disables the neutrophil chemotactic gradient. T. denticola 
major outer sheath protein (Msp) is one of its most important virulence factors in contribut‐
ing to the disease progression. This membrane protein modulates neutrophil signaling path‐
ways involved in cytoskeletal dynamics that are relevant in chemotaxis and phagocytosis [70]. 
Msp controls neutrophil cytoskeletal functions like migration, adhesion, and cell shape. It also 
causes extracellular matrix degradation by stimulating the release of activated MMPs from 
neutrophils.
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9. Neutrophil persistence and chronic inflammation
Neutrophils are recruited to infection and inflammation sites by different chemoattractants 
such as interleukin 8 (IL‐8), complement fragment C5a, or chemokine CXCL5. They migrate 
through the junctional epithelium and finally arrive in the gingival sulcus and in gingival cre‐
vicular fluid. Neutrophils in saliva retain their phagocytic function, and their ability to gener‐
ate ROS [71, 72]. NETs containing trapped bacteria have been described within the gingival 
sulcus, in purulent periodontal pockets, and on the surface of gingival epithelial cells. On con‐
dition that neutrophils and NETs do not occur excessively and are rapidly cleared, relatively 
little damage to the adjacent tissues is induced. Nevertheless, it has been widely reported that 
neutrophils can be responsible for both host defense and host tissue damage. Release of pro‐
teolytic and collagenolytic enzymes as well as ROS within host tissues, often lead to extracel‐
lular matrix degradation and persistent inflammation, are the main causes of tissue damage. 
Normally, connective tissue is degraded to allow fast transmigration of neutrophils and other 
cells involved in wound healing but during periodontitis it produces a chronic inflammatory 
disease. Hence, inflammation overweighs resolution, and host tissue destruction becomes 
progressive, eventually resulting in pathological osteolysis and tooth loss [58].
10. Therapeutic approaches
As it was discussed along this chapter, it is clear that both, lack of neutrophils and excess of neu‐
trophils in the periodontium, can lead to periodontal disease. Because both situations involve 
IL‐17‐mediated inflammation and bone loss, it is conceivable that IL‐17 or IL‐17R inhibitors 
may be promising targets for treatment of human periodontitis. By blocking IL‐17 actions, 
neutrophil recruitment to the periodontium would be reduced and in consequence, the inflam‐
mation state would also be reduced. This should prevent tissue damage and loss of bone.
In chronic periodontitis, periodontal bacteria activate neutrophil subversion pathways that 
allow bacteria to escape neutrophil killing. For example, P. aeruginosa biofilms produce bac‐
terial surfactants that induce rapid neutrophil death [59], and Aggregatibacter actinomycetem-
comitans and S. aureus produce bacterial toxins that induce neutrophil lysis and degranulation 
[61–63]. These bacterial products could be neutralized with antibodies or novel pharmaceuti‐
cal drugs to prevent their negative effects on neutrophils. Also, P. gingivalis can manipulate 
complement to induce bacterial persistence. Thus, complement components are also good 
therapeutic targets. In fact, in preclinical models of periodontitis the use of complement inhib‐
itors has led to a reduction of the inflammatory state [73, 74]. In addition, several bacteria 
including P. gingivalis can induce cells such as fibroblasts to produce IL‐8 and recruit more 
neutrophils to the inflamed periodontal tissues [68, 69]. Blocking IL‐8 is another interesting 
therapeutic strategy for reducing periodontitis. Several anti‐IL‐8 blocking antibodies are avail‐
able. Their potential benefit in periodontal disease should be evaluated in the near future.
Del‐1 is another promising candidate molecule to be used therapeutically to prevent neutro‐
phil recruitment and bone loss associated with periodontal inflammation [17]. Since Del‐1 
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blocks LFA‐1 binding to its ligand ICAM‐1 and prevents neutrophil transmigration [50], it 
could be administered to inflamed tissues, to reduce neutrophil recruitment, and to reduce 
inflammation. In fact, this is exactly what was found in a model of periodontitis with nonhu‐
man primates [75]. Local administration of Del‐1 also prevented inflammatory bone loss [75]. 
Preclinical studies for the use of Del‐1 are now underway.
All these potential therapeutic approaches promise a relief from periodontitis and perhaps 
other inflammatory disorders in the future.
11. Conclusion
Neutrophils are specialized phagocytes that coordinate and execute inflammation. Neutr‐
ophils constantly surveil oral tissues in order to guarantee oral health. Alterations in the 
neutrophil homeostasis (defects in recruitment and proper function) lead to periodontal 
diseases. Also, hyperactive neutrophils can exacerbate and even cause autoimmune and 
inflammatory diseases. Chronic infections driven by pathogenic biofilms indicate that the 
immune system fails to fully protect the host. New potential therapeutic approaches have 
been identified. They promise a relief from periodontitis and perhaps other inflammatory 
disorders.
Acknowledgements
This work was supported by Grant 254434 from Consejo Nacional de Ciencia y Tecnología, 
México (to Carlos Rosales), and by Grant PAPIIT IA202013 (to Eileen Uribe‐Querol) from 
Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de 
México, Mexico.
Author details
Carlos Rosales1 and Eileen Uribe‐Querol2*
*Address all correspondence to: euquerol@comunidad.unam.mx
1 Immunology Department, Instituto de Investigaciones Biomédicas, Universidad Nacional 
Autónoma de México, Mexico City, Mexico
2 Advanced Research Division, Facultad de Odontología, Universidad Nacional Autónoma 
de México, Mexico City, Mexico
Role of Neutrophils in Disease Pathogenesis82
References
[1] Petersen PE, Ogawa H: The global burden of periodontal disease: towards integration 
with chronic disease prevention and control. Periodontol. 2000 2012; 60:15–39. DOI: 
10.1111/j.1600‐0757.2011.00425.x.
[2] Rosier BT, De Jager M, Zaura E, Krom BP: Historical and contemporary hypotheses on 
the development of oral diseases: are we there yet? Front. Cell. Infect. Microbiol. 2014; 
4:92. DOI: 10.3389/fcimb.2014.00092
[3] Borregaard N: Neutrophils, from marrow to microbes. Immunity 2010; 33:657–670. DOI: 
10.1016/j.immuni.2010.11.011
[4] Tak T, Tesselaar K, Pillay J, Borghans JA, Koenderman L, Tesselaar K, Pillay J, Borghans 
JA, Koenderman L: What's your age again? Determination of human neutrophil half‐
lives revisited. J. Leukoc. Biol. 2013; 94:595–601. DOI: 10.1189/jlb.1112571
[5] Nauseef WM: How human neutrophils kill and degrade microbes: an integrated view. 
Immunol. Rev. 2007 219:88–102. DOI: 10.1111/j.1600‐065X.2007.00550.x
[6] Mócsai A: Diverse novel functions of neutrophils in immunity, inflammation, and 
beyond. J. Exp. Med. 2013; 210:1283–1299. DOI: 10.1084/jem.20122220.
[7] Mayadas TN, Cullere X, Lowell CA: The multifaceted functions of neutrophils. Annu. 
Rev. Pathol. 2014; 9:181–218. DOI: 10.1146/annurev‐pathol‐020712‐164023
[8] Hajishengallis E, Hajishengallis G: Neutrophil homeostasis and periodontal health in 
children and adults. J. Dent. Res. 2014 93:231–237. DOI: 10.1177/0022034513507956
[9] Delima AJ, Van Dyke TE: Origin and function of the cellular components in gingival 
crevice fluid. Periodontol. 2000. 2003; 31:55–76.
[10] von Vietinghoff S, Ley K: Homeostatic regulation of blood neutrophil counts. J. Immunol. 
2008; 181:5183–5188.
[11] Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A: Neutrophil function: from 
mechanisms to disease. Annu. Rev. Immunol. 2012; 30:459–489. DOI: 10.1146/annurev‐ 
immunol‐020711‐074942
[12] Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER: Neutrophil kinet‐
ics in health and disease. Trends Immunol. 2010; 31:318–324. DOI: 10.1016/j.it.2010.05.006.
[13] Weaver CT, Elson CO, Fouser LA, Kolls JK: The Th17 pathway and inflammatory dis‐
eases of the intestines, lungs, and skin. Annu. Rev. Pathol. 2013; 8:477–512. DOI: 10.1146/
annurev‐pathol‐011110‐130318
[14] Cortés‐Vieyra R, Rosales C, Uribe‐Querol E: Neutrophil functions in periodontal homeo‐
stasis. J. Immunol. Res. 2016; 2016:1396106. DOI: 10.1155/2016/1396106
Neutrophil Role in Periodontal Disease
http://dx.doi.org/10.5772/67789
83
[15] Ley K, Laudanna C, Cybulsky MI, Nourshargh S: Getting to the site of inflammation: the 
leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007; 7:678–689. DOI: 10.1038/
nri2156
[16] Kolaczkowska E, Kubes P: Neutrophil recruitment and function in health and inflamma‐
tion. Nat. Rev. Immunol. 2013; 13:159–175. DOI: 10.1038/nri3399
[17] Eskan MA, Jotwani R, Abe T, Chmelar J, Lim JH, Liang S, Ciero PA, Krauss JL, Li F, 
Rauner M et al: The leukocyte integrin antagonist Del‐1 inhibits IL‐17‐mediated inflam‐
matory bone loss. Nat. Immunol. 2012; 13:465–473. DOI: 10.1038/ni.2260.
[18] Kennedy AD, DeLeo FR: Neutrophil apoptosis and the resolution of infection. Immunol. 
Res. 2009; 43:25–61. DOI: 10.1007/s12026‐008‐8049‐6
[19] Martin C, Burdon PC, Bridger G, Gutierrez‐Ramos JC, Williams TJ, Rankin SM: Chemokines 
acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow 
and their return following senescence. Immunity 2003; 19:583–593.
[20] Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K: Phagocytosis of apoptotic 
neutrophils regulates granulopoiesis via IL‐23 and IL‐17. Immunity 2005; 22:285–294. 
DOI: 10.1016/j.immuni.2005.01.011
[21] Altznauer F, Martinelli S, Yousefi S, Thürig C, Schmid I, Conway EM, Schöni MH, 
Vogt P, Mueller C, Fey MF et al: Inflammation‐associated cell cycle‐independent block 
of apoptosis by survivin in terminally differentiated neutrophils. J. Exp. Med. 2004 
199:1343–1354. DOI: 10.1084/jem.20032033
[22] Belkaid Y, Naik S: Compartmentalized and systemic control of tissue immunity by com‐
mensals. Nat. Immunol. 2013 14:646–653. DOI: 10.1038/ni.2604
[23] Belkaid Y: Tailored immunity at mucosae. Immunol. Rev. 2014; 260:5–7. DOI: 10.1111/
imr.12197
[24] Curtis MA, Zenobia C, Darveau RP: The relationship of the oral microbiotia to periodontal 
health and disease. Cell Host Microbe 2011 10:302–306. DOI: 10.1016/j.chom.2011.09.008
[25] Pham CT: Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. 
Immunol. 2006 6:541–550. DOI: 10.1038/nri1841
[26] Faurschou M, Borregaard N: Neutrophil granules and secretory vesicles in inflamma‐
tion. Microbes Infect. 2003; 5:1317–1327.
[27] Sengeløv H, Follin P, Kjeldsen L, Lollike K, Dahlgren CNB: Mobilization of granules 
and secretory vesicles during in vivo exudation of human neutrophils. J. Immunol. 1995; 
154:4157–4165.
[28] Sengeløv H, Kjeldsen L, Borregaard N: Control of exocytosis in early neutrophil activa‐
tion. J. Immunol. 1993; 150:1535–1543.
Role of Neutrophils in Disease Pathogenesis84
[29] Zenobia C, Luo XL, Hashim A, Abe T, Jin L, Chang Y, Jin ZC, Sun JX, Hajishengallis G, 
Curtis MA et al: Commensal bacteria‐dependent select expression of CXCL2 contributes to 
periodontal tissue homeostasis. Cell. Microbiol. 2013 15:1419–1426. DOI: 10.1111/cmi.12127
[30] Matute JD, Arias AA, Wright NA, Wrobel I, Waterhouse CC, Li XJ, Marchal CC, Stull ND, 
Lewis DB, Steele M et al: A new genetic subgroup of chronic granulomatous disease with 
autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH 
oxidase activity. Blood 2009; 114:3309–3315. DOI: 10.1182/blood‐2009‐07‐231498
[31] Soler‐Palacín P, Margareto C, Llobet P, Asensio O, Hernández M, Caragol I, Español T: 
Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol. 
Immunopathol. 2007; 35:83–89.
[32] Lindhe J, Lang NP, Kariing T: Clinical Periodontology and Implant Dentistry. Vol. 1, 
Fifth edition. Oxford: Blackwell Munksgaard; 2008.
[33] Zhang D, Chen G, Manwani D, Mortha A, Xu C, Faith JJ, Burk RD, Kunisaki Y, Jang JE, 
Scheiermann C et al: Neutrophil ageing is regulated by the microbiome. Nature 2015; 
525:528–532. DOI: 10.1038/nature15367
[34] Sørensen OE, Clemmensen SN, Dahl SL, Østergaard O, Heegaard NH, Glenthøj A, 
Nielsen FC, Borregaard N: Papillon‐Lefèvre syndrome patient reveals species‐depen‐
dent requirements for neutrophil defenses. J. Clin. Invest. 2014; 124:4539–4548. DOI: 
10.1172/JCI76009
[35] Roberts H, White P, Dias I, McKaig S, Veeramachaneni R, Thakker N, Grant M, Chapple 
I: Characterization of neutrophil function in Papillon‐Lefèvre syndrome. J. Leukoc. Biol. 
2016; 100:433–444. DOI: 10.1189/jlb.5A1015‐489R
[36] Perera NC, Wiesmüller KH, Larsen MT, Schacher B, Eickholz P, Borregaard N, Jenne 
DE: NSP4 is stored in azurophil granules and released by activated neutrophils as active 
endoprotease with restricted specificity. J. Immunol. 2013; 191:2700–2707. DOI: 10.4049/
jimmunol.1301293
[37] Uriarte SM, Edmisson JS, Jimenez‐Flores E: Human neutrophils and oral microbiota: a 
constant tug‐of‐war between a harmonious and a discordant coexistence. Immunol. Rev. 
2016; 273:282–298. DOI: 10.1111/imr.12451
[38] Eke PI, Dye BA, Wei L, Slade GD, Thornton‐Evans GO, Borgnakke WS, Taylor GW, 
Page RC, Beck JD, Genco RJ: Update on prevalence of periodontitis in adults in the 
United States: NHANES 2009 to 2012. J. Periodontol. 2015; 86:611–622. DOI: 10.1902/
jop.2015.140520
[39] Zadeh HH, Nichols FC, Miyasaki KT: The role of the cell‐mediated immune response 
to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontitis. 
Periodontol. 2000 1999; 20:239–288.
[40] Borgnakke WS: Does treatment of periodontal disease influence systemic disease? Dent. 
Clin. North Am. 2015 59:885–917. DOI: 10.1016/j.cden.2015.06.007
Neutrophil Role in Periodontal Disease
http://dx.doi.org/10.5772/67789
85
[41] Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K: Relationship between 
periodontal infections and systemic disease. Clin. Microbiol. Infect. 2007; 13:3–10. DOI: 
10.1111/j.1469‐0691.2007.01798.x
[42] Rivera MF, Lee JY, Aneja M, Goswami V, Liu L, Velsko IM, Chukkapalli SS, Bhattacharyya 
I, Chen H, Lucas AR et al: Polymicrobial infection with major periodontal pathogens 
induced periodontal disease and aortic atherosclerosis in hyperlipidemic ApoE(null) 
mice. PLoS One 2013; 8:e57178. DOI: 10.1371/journal.pone.0057178
[43] Daniel R, Gokulanathan S, Shanmugasundaram N, Lakshmigandhan M, Kavin T: 
Diabetes and periodontal disease. J. Pharm. Bioallied Sci. 2012 4:S280–S282. DOI: 10.4103/ 
0975‐7406.100251
[44] Lakschevitz F, Aboodi G, Tenenbaum H, Glogauer M: Diabetes and periodontal dis‐
eases: interplay and links. Curr. Diabetes Rev. 2011; 7:433–439.
[45] Lamster IB, Pagan M: Periodontal disease and the metabolic syndrome. Int. Dent. J. 2016; 9. 
DOI: 10.1111/idj.12264
[46] Dababneh R, Al‐Wahadneh AM, Hamadneh S, Khouri A, Bissada NF: Periodontal mani‐
festation of leukocyte adhesion deficiency type I. J. Periodontol. 2008; 79:764–768. DOI: 
10.1902/jop.2008.070323
[47] Moutsopoulos NM, Konkel J, Sarmadi M, Eskan MA, Wild T, Dutzan N, Abusleme L, 
Zenobia C, Hosur KB, Abe T et al: Defective neutrophil recruitment in leukocyte adhe‐
sion deficiency type I disease causes local IL‐17‐driven inflammatory bone loss. Sci. 
Transl. Med. 2014; 6:229ra240. DOI: 10.1126/scitranslmed.3007696
[48] Ryder MI: Comparison of neutrophil functions in aggressive and chronic periodontitis. 
Periodontol. 2000 2010; 53:124–137. DOI: 10.1111/j.1600‐0757.2009.00327.x
[49] Aboodi GM, Goldberg MB, Glogauer M: Refractory periodontitis population character‐
ized by a hyperactive oral neutrophil phenotype. J. Periodontol. 2011; 82:726–733. DOI: 
10.1902/jop.2010.100508
[50] Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L, Economopoulou M, 
Kundu RK, Orlandi A, Zheng YY, Prieto DA et al: Del‐1, an endogenous leukocyte‐endo‐
thelial adhesion inhibitor, limits inflammatory cell recruitment. Science 2008; 322:1101–
1104. DOI: 10.1126/science.1165218
[51] Berezow AB, Darveau RP: Microbial shift and periodontitis. Periodontol. 2000 2011 
55:36–47. DOI: 10.1111/j.1600‐0757.2010.00350.x
[52] Griffen AL, Beall CJ, Firestone ND, Gross EL, Difranco JM, Hardman JH, Vriesendorp B, 
Faust RA, Janies DA, Leys EJ: CORE: a phylogenetically‐curated 16S rDNA database of 
the core oral microbiome. PLoS One 2011 6:e19051. DOI: 10.1371/journal.pone.0019051
[53] Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan A, Wade WG: 
The human oral microbiome. J. Bacteriol. 2010; 192:5002–5017. DOI: 10.1128/JB.00542‐10
Role of Neutrophils in Disease Pathogenesis86
[54] Wade WG: Has the use of molecular methods for the characterization of the human oral 
microbiome changed our understanding of the role of bacteria in the pathogenesis of peri‐
odontal disease? J. Clin. Periodontol. 2011; 38:7–16. DOI: 10.1111/j.1600‐051X.2010.01679.x
[55] Hajishengallis GJLR: Dancing with the stars: how choreographed bacterial interactions 
dictate nososymbiocity and give rise to keystone pathogens, accessory pathogens, and 
pathobionts. Trends Microbiol. 2016; 24:477–489. DOI: 10.1016/j.tim.2016.02.010
[56] Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL: Microbial complexes in sub‐
gingival plaque. J. Clin. Periodontol. 1998; 25:134–144.
[57] Costalonga M, Herzberg MC: The oral microbiome and the immunobiology of periodon‐
tal disease and caries. Immunol. Lett. 2014 162:22–38. DOI: 10.1016/j.imlet.2014.08.017
[58] Hirschfeld J: Dynamic interactions of neutrophils and biofilms. J. Oral. Microbiol. 2014; 
6:26102. DOI: 10.3402/jom.v6.26102
[59] Jensen PØ, Bjarnsholt T, Phipps R, Rasmussen TB, Calum H, Christoffersen L, Moser C, 
Williams P, Pressler T, Givskov M et al: Rapid necrotic killing of polymorphonuclear leuko‐
cytes is caused by quorum‐sensing‐controlled production of rhamnolipid by Pseudomonas 
aeruginosa. Microbiology 2007; 153:1329–1338. DOI: 10.1099/mic.0.2006/003863‐0
[60] Bjarnsholt T, Jensen PØ, Burmølle M, Hentzer M, Haagensen JA, Hougen HP, Calum 
H, Madsen KG, Moser C, Molin S et al: Pseudomonas aeruginosa tolerance to tobramycin, 
hydrogen peroxide and polymorphonuclear leukocytes is quorum‐sensing dependent. 
Microbiology 2005; 151:373–383. DOI: 10.1099/mic.0.27463‐0
[61] Claesson R, Johansson A, Belibasakis G, Hänström L, Kalfas S: Release and activation 
of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of 
Actinobacillus actinomycetemcomitans. J. Periodontal. Res. 2002; 37:353–359.
[62] Johansson A, Claesson R, Belibasakis G, Makoveichuk E, Hänström L, Olivecrona G, 
Sandström G, Kalfas S: Protease inhibitors, the responsible components for the serum‐
dependent enhancement of Actinobacillus actinomycetemcomitans leukotoxicity. Eur. J. 
Oral Sci. 2001; 109:335–341.
[63] Anwar S, Prince LR, Foster SJ, Whyte MK, Sabroe I: The rise and rise of Staphylococcus 
aureus: laughing in the face of granulocytes. Clin. Exp. Immunol. 2009; 157:216–224. DOI: 
10.1111/j.1365‐2249.2009.03950.x
[64] Papo N, Shai Y: A molecular mechanism for lipopolysaccharide protection of Gram‐neg‐
ative bacteria from antimicrobial peptides. J. Biol. Chem. 2005; 280:10378–10387. DOI: 
10.1074/jbc.M412865200
[65] Yamanaka T, Furukawa T, Matsumoto‐Mashimo C, Yamane K, Sugimori C, Nambu T, 
Mori N, Nishikawa H, Walker CB, Leung KP et al: Gene expression profile and pathoge‐
nicity of biofilm‐forming Prevotella intermedia strain 17. BMC Microbiol. 2009; 9:99. DOI: 
10.1186/1471‐2180‐9‐11
Neutrophil Role in Periodontal Disease
http://dx.doi.org/10.5772/67789
87
[66] Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP: Survival 
of Staphylococcus aureus inside neutrophils contributes to infection. J. Immunol. 2000; 
164:3712–3722.
[67] Mydel P, Takahashi Y, Yumoto H, Sztukowska M, Kubica M, Gibson FCr, Kurtz DMJ, 
Travis J, Collins LV, Nguyen KA et al: Roles of the host oxidative immune response 
and bacterial antioxidant rubrerythrin during Porphyromonas gingivalis infection. PLoS 
Pathog. 2006; 2:e76. DOI: 10.1371/journal.ppat.0020076
[68] Tamura M, Tokuda M, Nagaoka S, Takada H: Lipopolysaccharides of Bacteroides interme-
dius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce inter‐
leukin‐8 gene expression in human gingival fibroblast cultures. Infect. Immun. 1992; 
11:4932–4937.
[69] Belibasakis GN, Thurnheer T, Bostanci N: Interleukin‐8 responses of multi‐layer gingi‐
val epithelia to subgingival biofilms: role of the “red complex” species. PLoS One 2013; 
8:e81581. DOI: 10.1371/journal.pone.0081581
[70] Amin M, Grove DA, Kapus A, Glogauer M, Ellen RP: An actin‐stabilizing peptide conju‐
gate deduced from the major outer sheath protein of the bacterium Treponema denticola. 
Cell Motil. Cytoskeleton 2007; 64:662–674. DOI: 10.1002/cm.20213
[71] Lukac J, Mravak‐Stipetić M, Knezević M, Vrcek J, Sistig S, Ledinsky M, Kusić Z: 
Phagocytic functions of salivary neutrophils in oral mucous membrane diseases. J. Oral 
Pathol. Med. 2003; 32:271–274.
[72] Takubo T, Yamane T, Tsuda I, Tagawa S, Tatsumi N: Polymorphonuclear neutrophils in 
saliva and blood: a comparative study of morphology, function and phenotype. Br. J. 
Biomed. Sci. 1997 54:260–266.
[73] Hajishengallis G, Maekawa T, Abe T, Hajishengallis E, Lambris JD: Complement involve‐
ment in periodontitis: molecular mechanisms and rational therapeutic approaches. Adv. 
Exp. Med. Biol. 2015; 865:57–74. DOI: 10.1007/978‐3‐319‐18603‐0_4
[74] Maekawa T, Abe T, Hajishengallis E, Hosur KB, DeAngelis RA, Ricklin D, Lambris JD, 
Hajishengallis G: Genetic and intervention studies implicating complement C3 as a 
major target for the treatment of periodontitis. J. Immunol. 2014; 192:6020–6027. DOI: 
10.4049/jimmunol.1400569
[75] Shin J, Maekawa T, Abe T, Hajishengallis E, Hosur K, Pyaram K, Mitroulis I, Chavakis T, 
Hajishengallis G: DEL‐1 restrains osteoclastogenesis and inhibits inflammatory bone 
loss in nonhuman primates. Sci. Transl. Med. 2015; 7:307ra155. DOI: 10.1126/scitrans‐
lmed.aac5380
Role of Neutrophils in Disease Pathogenesis88
